Morgan Stanley upgrades Synopsys to Overweight, keeps $500 target

  • Morgan Stanley upgraded Synopsys to Overweight from Equal-Weight and retained its $500 price target.
  • Synopsys reported $3.91 non-GAAP EPS and $2.48 billion revenue in fiscal Q3 2026.
  • Morgan Stanley downgraded Infineon and reduced price targets for ASML and BE Semiconductor.

Morgan Stanley upgraded Synopsys to Overweight from Equal-Weight and maintained its $500 price target, describing the recent share-price decline as a buying opportunity. The bank said progress on Ansys integration, renewed double-digit electronic design automation growth and the strategic value of co-design capabilities justified the change, while strong artificial-intelligence demand and a broadening recovery support its constructive sector view. Synopsys shares were around $393.84, down roughly 5.4% intraday when the note was published. The company reported fiscal third-quarter 2026 non-GAAP EPS of $3.91 and revenue of $2.48 billion, above estimates of $3.67 and $2.44 billion, respectively, and raised full-year guidance. Morgan Stanley highlighted Multiphysics Fusion, physical AI simulation tools and the Factory 2 IP framework. Baird separately upgraded the shares to Outperform and raised its target to $560, while Benchmark maintained a positive rating. Morgan Stanley downgraded Infineon and cut its targets for ASML and BE Semiconductor.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.